2018-2023 Global Carcinoembryonic Antigen (CEA) Market Report (Status and Outlook)

October 2018 | 119 pages | ID: 2B4B239389DEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Carcinoembryonic Antigen (CEA) market for 2018-2023.

Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion.
Increasing consumption of alcohol and sedentary lifestyle are likely to boost the growth of colorectal cancer over the forecast period.
Over the next five years, LPI(LP Information) projects that Carcinoembryonic Antigen (CEA) will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Carcinoembryonic Antigen (CEA) market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• CD66a
• CD66b
• CD66d
• CD66e
• CD66f

Segmentation by application:

• Colorectal Cancer
• Pancreatic Cancer
• Ovarian Cancer
• Breast Cancer
• Thyroid Cancer
• Others

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Roche Diagnostics
• Abbott Diagnostics
• Quest Diagnostics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Carcinoembryonic Antigen (CEA) market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Carcinoembryonic Antigen (CEA) market by identifying its various subsegments.
• Focuses on the key global Carcinoembryonic Antigen (CEA) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Carcinoembryonic Antigen (CEA) with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Carcinoembryonic Antigen (CEA) submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Carcinoembryonic Antigen (CEA) Market Size 2013-2023
  2.1.2 Carcinoembryonic Antigen (CEA) Market Size CAGR by Region
2.2 Carcinoembryonic Antigen (CEA) Segment by Type
  2.2.1 CD66a
  2.2.2 CD66b
  2.2.3 CD66c
  2.2.4 CD66d
  2.2.5 CD66e
  2.2.6 CD66f
2.3 Carcinoembryonic Antigen (CEA) Market Size by Type
  2.3.1 Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
  2.3.2 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Type (2013-2018)
2.4 Carcinoembryonic Antigen (CEA) Segment by Application
  2.4.1 Colorectal Cancer
  2.4.2 Pancreatic Cancer
  2.4.3 Ovarian Cancer
  2.4.4 Breast Cancer
  2.4.5 Thyroid Cancer
  2.4.6 Others
2.5 Carcinoembryonic Antigen (CEA) Market Size by Application
  2.5.1 Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
  2.5.2 Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate by Application (2013-2018)

3 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) BY PLAYERS

3.1 Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Players
  3.1.1 Global Carcinoembryonic Antigen (CEA) Market Size by Players (2016-2018)
  3.1.2 Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Players (2016-2018)
3.2 Global Carcinoembryonic Antigen (CEA) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CARCINOEMBRYONIC ANTIGEN (CEA) BY REGIONS

4.1 Carcinoembryonic Antigen (CEA) Market Size by Regions
4.2 Americas Carcinoembryonic Antigen (CEA) Market Size Growth
4.3 APAC Carcinoembryonic Antigen (CEA) Market Size Growth
4.4 Europe Carcinoembryonic Antigen (CEA) Market Size Growth
4.5 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Growth

5 AMERICAS

5.1 Americas Carcinoembryonic Antigen (CEA) Market Size by Countries
5.2 Americas Carcinoembryonic Antigen (CEA) Market Size by Type
5.3 Americas Carcinoembryonic Antigen (CEA) Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Carcinoembryonic Antigen (CEA) Market Size by Countries
6.2 APAC Carcinoembryonic Antigen (CEA) Market Size by Type
6.3 APAC Carcinoembryonic Antigen (CEA) Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Carcinoembryonic Antigen (CEA) by Countries
7.2 Europe Carcinoembryonic Antigen (CEA) Market Size by Type
7.3 Europe Carcinoembryonic Antigen (CEA) Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Carcinoembryonic Antigen (CEA) by Countries
8.2 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type
8.3 Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL CARCINOEMBRYONIC ANTIGEN (CEA) MARKET FORECAST

10.1 Global Carcinoembryonic Antigen (CEA) Market Size Forecast (2018-2023)
10.2 Global Carcinoembryonic Antigen (CEA) Forecast by Regions
  10.2.1 Global Carcinoembryonic Antigen (CEA) Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Carcinoembryonic Antigen (CEA) Forecast by Type
10.8 Global Carcinoembryonic Antigen (CEA) Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Roche Diagnostics
  11.1.1 Company Details
  11.1.2 Carcinoembryonic Antigen (CEA) Product Offered
  11.1.3 Roche Diagnostics Carcinoembryonic Antigen (CEA) Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Roche Diagnostics News
11.2 Abbott Diagnostics
  11.2.1 Company Details
  11.2.2 Carcinoembryonic Antigen (CEA) Product Offered
  11.2.3 Abbott Diagnostics Carcinoembryonic Antigen (CEA) Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Abbott Diagnostics News
11.3 Quest Diagnostics
  11.3.1 Company Details
  11.3.2 Carcinoembryonic Antigen (CEA) Product Offered
  11.3.3 Quest Diagnostics Carcinoembryonic Antigen (CEA) Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Quest Diagnostics News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Carcinoembryonic Antigen (CEA)
Figure Carcinoembryonic Antigen (CEA) Report Years Considered
Figure Market Research Methodology
Figure Global Carcinoembryonic Antigen (CEA) Market Size Growth Rate 2013-2023 ($ Millions)
Table Carcinoembryonic Antigen (CEA) Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of CD66a
Table Major Players of CD66b
Table Major Players of CD66c
Table Major Players of CD66d
Table Major Players of CD66e
Table Major Players of CD66f
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure Global CD66a Market Size Growth Rate
Figure Global CD66b Market Size Growth Rate
Figure Global CD66c Market Size Growth Rate
Figure Global CD66d Market Size Growth Rate
Figure Global CD66e Market Size Growth Rate
Figure Global CD66f Market Size Growth Rate
Figure Carcinoembryonic Antigen (CEA) Consumed in Colorectal Cancer
Figure Global Carcinoembryonic Antigen (CEA) Market: Colorectal Cancer (2013-2018) ($ Millions)
Figure Global Colorectal Cancer YoY Growth ($ Millions)
Figure Carcinoembryonic Antigen (CEA) Consumed in Pancreatic Cancer
Figure Global Carcinoembryonic Antigen (CEA) Market: Pancreatic Cancer (2013-2018) ($ Millions)
Figure Global Pancreatic Cancer YoY Growth ($ Millions)
Figure Carcinoembryonic Antigen (CEA) Consumed in Ovarian Cancer
Figure Global Carcinoembryonic Antigen (CEA) Market: Ovarian Cancer (2013-2018) ($ Millions)
Figure Global Ovarian Cancer YoY Growth ($ Millions)
Figure Carcinoembryonic Antigen (CEA) Consumed in Breast Cancer
Figure Global Carcinoembryonic Antigen (CEA) Market: Breast Cancer (2013-2018) ($ Millions)
Figure Global Breast Cancer YoY Growth ($ Millions)
Figure Carcinoembryonic Antigen (CEA) Consumed in Thyroid Cancer
Figure Global Carcinoembryonic Antigen (CEA) Market: Thyroid Cancer (2013-2018) ($ Millions)
Figure Global Thyroid Cancer YoY Growth ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Colorectal Cancer Growth Rate
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Pancreatic Cancer Growth Rate
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Ovarian Cancer Growth Rate
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Breast Cancer Growth Rate
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Thyroid Cancer Growth Rate
Figure Global Carcinoembryonic Antigen (CEA) Market Size in Others Growth Rate
Table Global Carcinoembryonic Antigen (CEA) Revenue by Players (2016-2018) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players (2016-2018)
Figure Global Carcinoembryonic Antigen (CEA) Revenue Market Share by Players in 2017
Table Global Carcinoembryonic Antigen (CEA) Key Players Head office and Products Offered
Table Carcinoembryonic Antigen (CEA) Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Carcinoembryonic Antigen (CEA) Market Size by Regions 2013-2018 ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Regions 2013-2018
Figure Global Carcinoembryonic Antigen (CEA) Market Size Market Share by Regions 2013-2018
Figure Americas Carcinoembryonic Antigen (CEA) Market Size 2013-2018 ($ Millions)
Figure APAC Carcinoembryonic Antigen (CEA) Market Size 2013-2018 ($ Millions)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size 2013-2018 ($ Millions)
Table Americas Carcinoembryonic Antigen (CEA) Market Size by Countries (2013-2018) ($ Millions)
Table Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries (2013-2018)
Figure Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries in 2017
Table Americas Carcinoembryonic Antigen (CEA) Market Size by Type (2013-2018) ($ Millions)
Table Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Type in 2017
Table Americas Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018) ($ Millions)
Table Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure Americas Carcinoembryonic Antigen (CEA) Market Size Market Share by Application in 2017
Figure United States Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Canada Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Table APAC Carcinoembryonic Antigen (CEA) Market Size by Countries (2013-2018) ($ Millions)
Table APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries (2013-2018)
Figure APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries in 2017
Table APAC Carcinoembryonic Antigen (CEA) Market Size by Type (2013-2018) ($ Millions)
Table APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Type in 2017
Table APAC Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018) ($ Millions)
Table APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure APAC Carcinoembryonic Antigen (CEA) Market Size Market Share by Application in 2017
Figure China Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Korea Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure India Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Australia Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Countries (2013-2018) ($ Millions)
Table Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries in 2017
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Type (2013-2018) ($ Millions)
Table Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Type in 2017
Table Europe Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018) ($ Millions)
Table Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size Market Share by Application in 2017
Figure Germany Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure France Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure UK Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Italy Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Russia Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Spain Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Countries in 2017
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Type in 2017
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size Market Share by Application in 2017
Figure Egypt Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Israel Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Carcinoembryonic Antigen (CEA) Market Size Growth 2013-2018 ($ Millions)
Figure Global Carcinoembryonic Antigen (CEA) arket Size Forecast (2018-2023) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share Forecast by Regions
Figure Americas Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure APAC Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Europe Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure United States Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Canada Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Mexico Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Brazil Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure China Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Japan Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Korea Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure India Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Australia Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Germany Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure France Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure UK Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Italy Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Russia Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Spain Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Egypt Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure South Africa Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Israel Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure Turkey Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Figure GCC Countries Carcinoembryonic Antigen (CEA) Market Size 2018-2023 ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share Forecast by Type (2018-2023)
Table Global Carcinoembryonic Antigen (CEA) Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Carcinoembryonic Antigen (CEA) Market Size Market Share Forecast by Application (2018-2023)
Table Roche Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Roche Diagnostics Carcinoembryonic Antigen (CEA) Revenue and Gross Margin (2016-2018)
Figure Roche Diagnostics Carcinoembryonic Antigen (CEA) Market Share (2016-2018)
Table Abbott Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Abbott Diagnostics Carcinoembryonic Antigen (CEA) Revenue and Gross Margin (2016-2018)
Figure Abbott Diagnostics Carcinoembryonic Antigen (CEA) Market Share (2016-2018)
Table Quest Diagnostics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Quest Diagnostics Carcinoembryonic Antigen (CEA) Revenue and Gross Margin (2016-2018)
Figure Quest Diagnostics Carcinoembryonic Antigen (CEA) Market Share (2016-2018)